Epilepsy and Sudden Death
Lancet 348:1324-1325, Nashef,L.&Brown,S., 1996
Practice Parameter:Genetic Testing Alert
Pract Comm Genet Testing Task Force AAN, Neurol 47:1343-13441996., , 1996
Guidelines for Physicians with Patients on IFNB-1b:The Use of an Assay for Neutralizing Antibodies (NAB)
Neurol 47:865-866, Paty,D.,et al, 1996
Interferon Beta in Multiple Sclerosis
BMJ 313:1159, 1157, 1195996., Richards,R.G., 1996
Living with Parkinson's Disease
NEJM 334:114-116, Salzman,E.W., 1996
Factors Delaying Hospital Admission After Acute Stroke
Stroke 27:398-400, Fogelholm,R.,et al, 1996
Consensus Statement on the Definition of Orthostatic Hypotension, Pure Autonomic Failure, and Multiple System Atrophy
Neurol 46:1470, Schatz,I.J.,et al, 1996
Thrombolytic Therapy for Acute Ischemic Stroke-Summary Statement
Report of the Quality Standards Subcommittee of the AAN, Neurol 47:835-8391996., , 1996
Factors Delaying Hospital Admission in Acute Stroke:The Copenhagen Stroke Study
Neurol 47:383-387, Jorgensen,H.S.,et al, 1996
US Nat'l Survey of Phy Pract for 2nd & Tertiary Prevent of Ischemic Stroke, Med Therapy in Carotid Art Stenosis
Stroke 27:1473-1478, Goldstein,L.B.,et al, 1996
Results of a Computerized Screening of Stroke Patients for Unjustified Hospital Stay
Stroke 27:639-644, Goldman,R.S.,et al, 1996
Apolipoprotein E Genotyping in Alzheimer's Disease
Lancet 347:1091-1095, Tanzi,R.,et al, 1996
US NEurologists:Attitudes on the US Health Care System
Neurol 47:279-287, Ringel,S.P.,et al, 1996
Evidence-Based Medicine, Critical Pathways, Practice Guidelines, & Managed Care:Prevention & Care of Stroke
Arch Neurol 53:867-871, Ringel,S.P.&Hughes,R.L., 1996
Assessment of Plasmapheresis
Report of the Therapeutics and Technology Assessment Subcommittee of the AAN, Neurol 47:840-8431996., , 1996
Problems with Myofascial Pain Syndrome and Fibromyalgia Syndrome
Neurol 46:593-597, Bohr,T., 1996
Intravenous Immunoglobulin Treatment of Neurological Disease
JNNP 60:359-361, Otten,A.,et al, 1996
Cost-Effectiveness Analysis:What Is It and How Will It Influence Neurology
Ann Neurol 39:818-823, Holloway,R.G., 1996
Practice Parameters for the Diagnosis of Patients with Nervous System Lyme Borreliosis (Lyme Disease)
Neurol 46:619-627, 8811996., Halperin,J.J.,et al, 1996
Neuroimaging in the Emergency Patient Presenting with Seizure
Neurol 47:26-32, 2881996., Greenberg,M.K.,et al, 1996
Assessment:Electronystagmography, Report of the Therapeutics and Technology Assessment Subcommittee
Neurol 46:1763-1766, Ferguson,J.H.,et al, 1996
Practice Parameter:A Guideline for Discontinuing Antiepileptic Drugs in Seizure-Free Patients-Summary Statement
Neurol 47:600-602, Rosenberg,J.H., 1996
Practice Parameter:The Neurodiagnostic Evaluation of the Child with First Simple Febrile Seizure
Pediatrics 97:769-772, Bergman,D.A.,et al, 1996
Guidelines for Carotid Endarterectomy
Stroke 26:188-201, Moore,W.S.,et al, 1995
Safety and Efficacy of Ergotamine Tartrate & Dihydroergotamine in the Trmt of Migraine & Status Migrainosus
Neurol 45:577-584, Silberstein,S.D.,et al, 1995
Practice Parameter:Appropriate Use of Ergotamine Tartrate & Dihydroergotamine in the Trmt of Migraine & Status Migrainosus
Neurol 45:585-587, , 1995
Acute Viral Encephalitis in Childhood
BMJ 310:139-140, Kennedy,C., 1995
Dexamethasone Therapy for Children with Bacterial Meningitis
Pediatrics 95:21-28, 291995., Wald,E.R.,et al, 1995
Drug Treatment of Parkinson's Disease
BMJ 310:575-579, Quinn,N., 1995
Statement of Use of Apolipoprotein E Testing for Alzheimer Disease
JAMA 274:1627-1629, Farrer,L.A.,et al, 1995
Assessment:Neurological Evaluation of Male Sexual Dysfunction
Report of the Therapeutics & Tech Assess Subcommittee of the AAN, Neurol 45:2287-229295., , 1995
Hereditary Hemorrhagic Telangiectasia
NEJM 333:918-924, Guttmacher,A.E.,et al, 1995
Acute Bacterial meningitis
Lancet 346:1675-1680, Tunkel,A.R.&Scheld,W.M., 1995
Guidelines on the Detection of Paraneoplastic Anti-Neuronal-Specific Antibodies
Neurol 45:1937-1941, Moll,J.W.B.,et al, 1995
The Treatment of Acute Low Back Pain-Bed Rest, Exercises, or Ordinary Activity
NEJM 332:351-355, Malmivaara,A.,et al, 1995
Determining Brain Death in Adults
Neurol 45:1003-1011, Wijdicks,E.F.M., 1995
Practice Parameters for Determining Brain Death in Adults
Neurol 45:1012-1014, Rosenberg,J.H.,et al, 1995
Do-Not-Resuscitate Orders in Acute Stroke
Neurol 45:634-640, 6151995., Alexandrov,A.V.,et al, 1995
Endarterectomy for Asymptomatic Carotid Stenosis?
Lancet 345:1254-1255, Warlow,C., 1995
US National Survey of Physician Practices for the Secondary & Tertiary Prevention of Ischemic Stroke:Common Practices
Stroke 26:1607-1615, Goldstein,L.B.,et al, 1995
Practice Parameters:Assessment and Management of Patients in the Persistent Vegetative State
Neurol 45:1015-1018, Rosenberg,J.H.,et al, 1995
Commentary on the Practice Parameters for the Persistent Vegetative State
Neurol 45:859-860, Ashwal,S.,et al, 1995
Recommendations for Off-Label Use of Intravenously Administered Immunoglobulin Preparations
JAMA 273:1865-1870, Ratko,T.A.,et al, 1995
The Utility of the Electroencephalogram in the Eval of Pts Presenting with Headache, Review of Lit
Neurol 45:1263-1267, Gronseth,G.S.,et al, 1995
Variability in Brain Death Determination Practices in Children
JAMA 274:550-553, Mejia,R.E.&Pollack,M.M., 1995
Low Back Pain
BMJ 310:929-932, Jenner,J.R.&Barry,M., 1995
Patient Education and Health Promotion Can Be Effective in Parkinson's Disease:A Randomized Controlled Trial
Am J Med 97:429-435, Montgomery,E.B.,et al, 1994
The Effectiveness of Four Interventions for the Prevention of Low Back Pain
JAMA 272:1286-1291, Lahad,A.,et al, 1994
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
Stroke 25:2315-2328, Mayberg,M.R.,et al, 1994
Urgent Therapy for Acute Stroke:Effects of a Stroke Trial on Untreated Patients
Stroke 25:2132-2137, Barsan,W.G.,et al, 1994